bell
The current prices are delayed by 15 mins, login to check live prices.
Strides Pharma Science Ltd share price logo

Strides Pharma Science Ltd

(STAR)

₹715.05▲1.27%

as on 04:01PM, 13 Dec 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Strides Pharma Science Ltd Analyst Rating

based on 4 analysts

BUY

75.00%

Buy

0.00%

Hold

25.00%

Sell

Based on 4 analysts offering long term price targets for Strides Pharma Science Ltd. An average target of ₹1700.75

Source: S&P Global Market Intelligence

Strides Pharma Science Ltd Share analysis

Strides Pharma Science Ltd price forecast by 4 analysts

Upside of140.88%

High

₹1954

Target

₹1700.75

Low

₹1175

Strides Pharma Science Ltd target price ₹1700.75, a slight upside of 140.88% compared to current price of ₹715.05. According to 4 analysts rating.

Source: S&P Global Market Intelligence

Strides Pharma Science Ltd Performance

  • Day's Low

    Day's High

    ₹697
    ₹720.95

  • 52 Week's Low

    52 Week's High

    ₹532.65
    ₹1,675
1 Month Return-49.16 %
3 Month Return-47.88 %
1 Year Return+ 21.06 %
Previous Close₹706.05
Open₹709.85
Volume2.75L
Upper Circuit-
Lower Circuit-
Market Cap₹6,507.15Cr

Strides Pharma Science Ltd Key Statistics

P/E Ratio63.96
PEG Ratio2.89
Market Cap₹6,507.15 Cr
P/B Ratio2.02
EPS-4.49593788068675
Dividend Yield0.32
SectorPharmaceuticals
ROE1.87

Strides Pharma Science Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Strides Pharma Science Ltd
Strides Pharma Science Ltd
BUY₹6,507.15 Cr18.26%0.66-₹95 Cr₹4,051 Cr
Oxygenta Pharmaceutical Ltd
Oxygenta Pharmaceutical Ltd
NA₹326.45 Cr172.27%1.27NANA
Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Ltd
NA₹5,843.25 Cr468.1%0.50₹33 Cr₹204 Cr
Ind-Swift Ltd
Ind-Swift Ltd
NA₹159.73 Cr173.38%2.00₹14 Cr₹502 Cr
Glenmark Life Sciences Ltd
Glenmark Life Sciences Ltd
BUY₹12,698.69 Cr7.69%0.51NANA
See all

Strides Pharma Science Ltd Mutual Fund Holdings

About Strides Pharma Science Ltd

Strides Pharma Science Ltd is an integrated pharmaceutical company listed on the Indian stock exchange. They are focused on developing, manufacturing and marketing pharmaceutical products in India and overseas. With a strong presence in regulated and semi-regulated markets, they offer a wide array of products ranging from Tablets, Capsules, Powders and Oral Liquids to Ointments, Softgel Capsules and Injectables. Their portfolio of services includes Product Development, Contract Manufacturing, Regulatory and Quality Compliance Support and Supply Chain Solutions. Their commitment to quality and innovation, along with the ability to serve their clients with a reliable, cost-effective and timely product supply, has helped them gain a foothold in the pharmaceutical industry. With their focus on meeting the ever-changing needs of customers, Strides Pharma Science Ltd is uniquely positioned in the pharmaceutical landscape.

Share Price: ₹715.05 per share as on 13 Dec, 2024 04:01 PM
Market Capitalisation: ₹6,507.15Cr as of today
Revenue: ₹1,201.11Cr as on September 2024 (Q3 24)
Net Profit: ₹93.66Cr as on September 2024 (Q3 24)
Listing date: 02 Feb, 2000
Chairperson Name: Arun Kumar
OrganisationStrides Pharma Science Ltd
HeadquartersBangaluru
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Strides Pharma Science Ltd

  • Strides Pharma's OneSource Plans Stock Listing - 12 Dec, 2024

    Strides Pharma Science announced that its subsidiary, OneSource Specialty Pharma, aims to list shares on stock exchanges in Q4 FY25, with an Information Memorandum submission planned for December 2024.

  • OneSource Share Allotment Completed for Strides Pharma - 11 Dec, 2024

    Strides Pharma Science Ltd announced the completion of share allotment for OneSource Specialty Pharma, with eligible shareholders receiving one share for every two held. The listing is planned for FY25.

  • Strides Pharma Hits Upper Circuit on Strong Q2 Results - 10 Dec, 2024

    Strides Pharma Science stock surged 5% to ₹752.45 after reporting robust Q2FY25 results, with a 20.2% YoY revenue growth and a positive PAT of ₹106.47 crore.

  • Strides Pharma Stock Hits Upper Circuit Limit - 06 Dec, 2024

    Strides Pharma's stock reached a 5% upper circuit limit at ₹712.85. The record date for shareholders entitled to OneSource shares is December 6, 2024, under a scheme of arrangement.

  • Strides Pharma Reports Strong Profit Growth - 23 Nov, 2024

    Strides Pharma Science Ltd's market capitalization stands at Rs 13,876 crore, with shares closing at Rs 1,509, up 0.39%. The company reported a significant increase in consolidated net profit from Rs 19 crores in Q2FY23 to Rs 94 crores in Q2FY25, reflecting a 70% CAGR over three years.

  • Strides Pharma Surges on OneSource Approval News - 21 Nov, 2024

    Strides Pharma shares rose significantly after the NCLT approved the creation of OneSource Specialty Pharma, integrating specialized businesses and securing substantial investment. The stock is set for robust growth.

  • Strides Pharma Launches OneSource CDMO with NCLT Approval - 20 Nov, 2024

    Strides Pharma Science Ltd has received NCLT approval to create OneSource, India's first specialty pharma CDMO, backed by Rs 801 crore investment. OneSource will list on BSE and NSE, with shareholders receiving shares in a 1:2 ratio.

  • Strides Pharma Receives NCLT Approval for OneSource - 19 Nov, 2024

    Strides Pharma has received NCLT approval for OneSource, India's first specialty pharma CDMO, backed by Rs 801 crore investment. OneSource aims for robust growth and is expected to list on stock exchanges by FY25.

Insights on Strides Pharma Science Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 1.07K Cr → 1.22K Cr (in ₹), with an average increase of 6.6% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 18.18 Cr → 93.23 Cr (in ₹), with an average increase of 49.4% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 26.71% to 30.08% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 10.50% to 10.80% in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 136.8% return, outperforming this stock by 92.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 62.8% return, outperforming this stock by 41.7%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 28.87% to 25.83% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, STAR stock has moved down by -49.2%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 25.86% to 25.84% in Sep 2024 quarter

Strides Pharma Science Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹999.43Cr (-)₹1,037.67Cr (↑3.83%)₹1,084.04Cr (↑4.47%)₹1,087.51Cr (↑0.32%)₹1,201.11Cr (↑10.45%)
Net Income-₹149.46Cr (-)₹54.06Cr (↓136.17%)₹10.44Cr (↓80.69%)₹68.31Cr (↑554.31%)₹93.66Cr (↑37.11%)
Net Profit Margin-14.95% (-)5.21% (↓134.85%)0.96% (↓81.57%)6.28% (↑554.17%)7.80% (↑24.20%)
Value in ₹ crore
Details2021202220232024
Total Assets₹5,264.26Cr (-)₹5,478.46Cr (↑4.07%)₹5,658.16Cr (↑3.28%)₹5,871.07Cr (↑3.76%)
Total Liabilities₹2,016.20Cr (-)₹2,071.77Cr (↑2.76%)₹2,203.11Cr (↑6.34%)₹2,309.95Cr (↑4.85%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹137.64Cr (-)₹282.76Cr (↑105.43%)-₹282.69Cr (↓199.98%)₹241.74Cr (↓185.51%)-₹35.76Cr (↓114.79%)

Index Inclusions

BSE Healthcare

₹44,049.87

-0.29 (▲-127%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

BSE Small-Cap

₹56,957.46

-0.29 (▲-167.68%)

Strides Pharma Science Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
25.84%
-0.07
Foreign Institutions
30.08%
12.63
Mutual Funds
10.8%
2.83
Retail Investors
25.83%
-10.53
Others
7.45%
-7.60

Strides Pharma Science Ltd Key Indicators

Details20202021202220232024
Return On Equity %3.752.445.290.611.87
Details20202021202220232024
Return On Assets %0.775.1-8.4-3.58-1.2
Details20202021202220232024
Book Value Per Share (₹)123.66135.68115.12106.52101.35
Details20202021202220232024
Earning Per Share (₹)1.512.59-23.15-10.3-4.5

Strides Pharma Science Ltd Valuation

Strides Pharma Science Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-409.04x)

July 5, 2021

Industry (56.92x)

December 12, 2024

Today (63.96x)

December 12, 2024

Highest (6307.66x)

September 27, 2024

LowHigh

Strides Pharma Science Ltd Earnings and Dividends

  • Strides Pharma Science Ltd Earnings Results

    Strides Pharma Science Ltd’s net profit jumped 170.98% since last year same period to ₹93.23Cr in the Q2 2024-2025. On a quarterly growth basis, Strides Pharma Science Ltd has generated 32.81% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Strides Pharma Science Ltd Dividends May,2024

    In the quarter ending March 2024, Strides Pharma Science Ltd has declared dividend of ₹2.50 - translating a dividend yield of 0.56%.

    Read More about Dividends

Strides Pharma Science Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Strides Pharma Science Ltd is currently in a Bearish trading position according to technical analysis indicators.

More on Technical Analysis

FAQs on Strides Pharma Science Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Strides Pharma Science Ltd shares.

Strides Pharma Science Ltd (STAR) share price today is ₹715.05

Strides Pharma Science Ltd is listed on NSE

Strides Pharma Science Ltd is listed on BSE

  • Today’s highest price of Strides Pharma Science Ltd is ₹720.95.
  • Today’s lowest price of Strides Pharma Science Ltd is ₹697.

PE Ratio of Strides Pharma Science Ltd is 63.96

PE ratio = Strides Pharma Science Ltd Market price per share / Strides Pharma Science Ltd Earnings per share

Today’s traded volume of Strides Pharma Science Ltd(STAR) is 2.75L.

Today’s market capitalisation of Strides Pharma Science Ltd(STAR) is ₹6507.15Cr.

Strides Pharma Science Ltd(STARPrice
52 Week High
₹1675
52 Week Low
₹532.65

Strides Pharma Science Ltd(STAR) share price is ₹715.05. It is down -57.31% from its 52 Week High price of ₹1675

Strides Pharma Science Ltd(STAR) share price is ₹715.05. It is up 34.24% from its 52 Week Low price of ₹532.65

Strides Pharma Science Ltd(STARReturns
1 Day Returns
9%
1 Month Returns
-49.16%
3 Month Returns
-47.88%
1 Year Returns
21.06%